Oxidative damage to cellular and isolated DNA by homocysteine: implications for carcinogenesis.
Homocysteine is considered to be an important risk factor for cancer as well as cardiovascular diseases. To clarify whether homocysteine has potential carcinogenicity, we investigated formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), which is known to be correlated with the incidence of cancer, induced by homocysteine in human cultured cell lines. Homocysteine increased the amount of 8-oxodG in human leukemia cell line HL-60, whereas the amount of 8-oxodG in its hydrogen peroxide (H(2)O(2))-resistant clone HP100 was not increased. We investigated the mechanism for oxidative DNA damage by homocysteine using (32)P-labeled DNA fragments obtained from human tumor suppressor genes and a proto-oncogene. There were two mechanisms by which homocysteine caused DNA damage in the presence of Cu(II). A low concentration of homocysteine (20 microM) frequently induced piperidine-labile sites at thymine residues, whereas a high concentration of homocysteine (100 microM) resulted in damage principally to guanine residues. Catalase inhibited DNA damage by 20 microM homocysteine, indicating the participation of H(2)O(2), but was ineffective in preventing DNA damage by 100 microM homocysteine. Experiments using a singlet oxygen probe showed that 100 microM homocysteine enhanced chemiluminescence intensity in deuterium oxide more than that in H(2)O. These results indicated that the metal-dependent DNA damage through H(2)O(2) is likely to be a more relevant mechanism for homocysteine carcinogenicity.
Oikawa
Shinji
S
Department of Environmental and Molecular Medicine, Mie University School of Medicine, Mie 514-8507, Japan.
Murakami
Katsuhiko
K
Kawanishi
Shosuke
S
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000818:Animals; D002273:Carcinogens / Q000378:metabolism / Q000494:pharmacology; D002417:Cattle; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003300:Copper / Q000378:metabolism; D003545:Cysteine / Q000378:metabolism / Q000494:pharmacology; D004247:DNA / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D004249:DNA Damage / Q000502:physiology*; D003849:Deoxyguanosine / Q000031:analogs & derivatives* / Q000378:metabolism; D016166:Free Radical Scavengers / Q000494:pharmacology; D006147:Guanine / Q000378:metabolism; D018922:HL-60 Cells / Q000187:drug effects; D006710:Homocysteine / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D008163:Luminescent Measurements; D018384:Oxidative Stress; D010761:Phosphorus Radioisotopes / Q000378:metabolism; D000090063:Proto-Oncogene Mas; D011721:Pyrenes / Q000032:analysis / Q000378:metabolism; D026082:Singlet Oxygen / Q000378:metabolism; D013941:Thymine / Q000378:metabolism; D013950:Thymus Gland / Q000502:physiology
D002273:Carcinogens; D016166:Free Radical Scavengers; C000715470:MAS1 protein, human; D010761:Phosphorus Radioisotopes; D000090063:Proto-Oncogene Mas; D011721:Pyrenes; D006710:Homocysteine; D026082:Singlet Oxygen; D006147:Guanine; D003300:Copper; D000080242:8-Hydroxy-2'-Deoxyguanosine; D004247:DNA; C043063:(2'-methoxyvinyl)pyrene; D003849:Deoxyguanosine; D003545:Cysteine; D013941:Thymine